At a glance
ClinicalIndex Comparison RecordN/ACompleted· 99 enrolled
Drug / intervention
Treatment with HydroPearl via radial accessdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
In Brief
An observational study evaluating Treatment with HydroPearl via radial access for Uterine Fibroid and 3 related conditions. Completed, enrolled 99 participants across 6 sites.
Detailed Summary
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUterine Fibroid, Arteriovenous Malformations, Hypervascular Tumors, Benign Prostatic Hyperplasia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedFeb 2020
Primary CompletionMar 2022
Study CompletionMar 2023
TodayJul 2026
First PostedFeb 17, 2020
Enrollment StartFeb 6, 2020
Primary CompletionMar 7, 2022
Study CompletionMar 11, 2023
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 6.4 years ago
Interventions
Treatment with HydroPearl via radial accessdevice
This is an observational study collecting data on patients who are already being treated with HydroPearl on-label per standard of care.